I have one quick question. The question of how we save money was raised. What's been identified at this committee so far is bulk buying, exclusive supply contracts, the savings from cost-related non-adherence, having a broad, independent national formulary, evidence-based prescribing, and streamlined administration. These are all features of national universal pharmacare plans that contribute to savings of money. In fact New Zealand—
